检索

期
标题
作者
卷 94, 编号 12 (2022)
Gout: from Hippocrates till the modern time
Guliaev S., Chebotareva N., Moiseev S.
PDF
(Rus)
卷 94, 编号 12 (2022)
Hyperuricemia and kidney damage in patients with cardiovascular disease: A review
Mironova O.
PDF
(Rus)
卷 93, 编号 5 (2021)
Advantages of the use of metformin in patients with impaired uric acid metabolism
Eliseev M., Panevin T., Zhelyabina O., Nasonov E.
PDF
(Rus)
卷 86, 编号 6 (2014)
Clinical value of the determination of markers for endothelial dysfunction (endothelin-1, microalbuminuria) and tubulointerstitial tissue lesion (Β2-microglobulin, monocyte chemotactic protein-1) in hypertensive patients with uric acid metabolic disorders
Stakhova T., Shcherbak A., Kozlovskaia L., Taranova M., Balkarov I.
卷 78, 编号 6 (2003)
Arterial hypertension, its metabolic aspects and function of the kidneys inconvalescents after hemorrhagic fever with renal syndrome
Pimenov L., Dudarev M., Vasilyev M.
卷 92, 编号 6 (2020)
Evaluation of a 12-week allopurinol-lowering therapy in combination with the non-steroidal anti-inflammatory drug meloxicam in patients with gout
Gromova M., Tsurko V., Kislyak O., Malysheva N.
PDF
(Rus)
卷 85, 编号 6 (2013)
Hyperuricemia and the problem of chronic kidney disease
Shcherbak A., Kozlovskaia L., Bobkova I., Balkarov I., Lebedeva M., Stakhova T.
卷 92, 编号 5 (2020)
Advantages of therapy with sodium glucose cotransporter type 2 inhibitors in patients with type 2 diabetes mellitus in combination with hyperuricemia and gout
Panevin T., Eliseev M., Shestakova M., Nasonov E.
PDF
(Rus)
卷 84, 编号 1 (2012)
Renal affection in gout
Egorov I., Tsurko V., Egorov I., Tsurko V.
卷 91, 编号 12 (2019)
Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice
Fomin V., Morosova T., Tsurko V.
PDF
(Rus)
卷 83, 编号 10 (2011)
Lozartan potential in hyperuricemia correction
Nedogoda S., Nedogoda S.
卷 91, 编号 5 (2019)
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy
Eliseev M., Novikova A.
PDF
(Rus)
卷 83, 编号 10 (2011)
Clinical implication of endothelial dysfunction in patients with essential arterial hypertension and urate dysbolism with renal damage
Stakhova T., Pulin A., Severova M., Shovskaya T., Minakova E., Oleynikova E., Lebedeva M., Stakhova T., Pulin A., Severova M., Shovskaya T., Minakova E., Oleinikova E., Lebedeva M.
卷 90, 编号 5 (2018)
Gout. New opportunities of diagnosis and treatment
Yakupova S.
PDF
(Rus)
卷 83, 编号 5 (2011)
Main factors of gender dimorphism of gout (estrogens and diuretics vs alcohol and genetics)
Barskova V., Eliseev M., Chikalenkova N., Barskova V., Eliseev M., Chikalenkova N.
卷 89, 编号 12-2 (2017)
A rationally grounded approach to treating gout with regard to its onset and course and the presence of comorbidity according to the European League against Rheumatism (EULAR 2016) recommendations
Tsurko V., Gromova M.
卷 83, 编号 6 (2011)
Hyperuricemia as a component of cardiorenal syndrome
Mukhin N., Fomin V., Lebedeva M., Mukhin N., Fomin V., Lebedeva M.
卷 93, 编号 9 (2021)
Prognostic impact of uric acid in patients with acute decompensated heart failure
Nasonova S., Lapteva A., Zhirov I., Mindzaev D., Tereshchenko S.
PDF
(Rus)
卷 89, 编号 5 (2017)
Independent risk factors for severe cardiovascular events in male patients with gout: Results of a 7-year prospective study
Eliseev M., Denisov I., Markelova E., Glukhova S., Nasonov E.
PDF
(Rus)
卷 79, 编号 11 (2004)
Arterial hypertension in adolescents with different physical constitution including those with signs of metabolic syndrome
Rovda Y., Kazakova L., Rovda T., Rovda E.
1 - 20 的 20 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##